These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3394194)

  • 1. [Eye function in patients with proliferative diabetic retinopathy following closed vitrectomy].
    Makhacheva ZA; Mironova EM
    Vestn Oftalmol; 1988; 104(2):22-5. PubMed ID: 3394194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of closed vitrectomy on eye function and the course of proliferative diabetic retinopathy].
    Fedorov SN; Makhacheva ZA; Glinchuk IaI; Mironova EM
    Vestn Oftalmol; 1985; 101(4):29-33. PubMed ID: 4060408
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fluorescent angiographic and rheographic evaluation of the ocular hemodynamics in patients with proliferative diabetic retinopathy after closed vitrectomy].
    Kishkina VIa; Semenov AD; Makhacheva ZA; Butiagin SV
    Vestn Oftalmol; 1989; 105(3):33-6. PubMed ID: 2749969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy.
    Okamoto F; Okamoto Y; Fukuda S; Hiraoka T; Oshika T
    Am J Ophthalmol; 2008 Jun; 145(6):1031-1036. PubMed ID: 18400203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood supply and microcirculation of the eye in different forms and stages of diabetic retinopathy].
    Saldan IR; Kozina LV; Bakuleva NV; Drachenko KG
    Oftalmol Zh; 1982; 37(8):473-7. PubMed ID: 7162740
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term functional effect of pars plana vitrectomy in complications of proliferative diabetic retinopathy].
    Chrapek O; Rehák J; Spacková K; Fric E
    Cesk Slov Oftalmol; 2006 Nov; 62(6):395-403. PubMed ID: 17319170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic vitrectomy: influence of lens status upon anatomic and visual outcomes.
    Schiff WM; Barile GR; Hwang JC; Tseng JJ; Cekiç O; Del Priore LV; Chang S
    Ophthalmology; 2007 Mar; 114(3):544-50. PubMed ID: 17169431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy.
    Savage HI; Hendrix JW; Peterson DC; Young H; Wilkinson CP
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4504-9. PubMed ID: 15557461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The visual outcome of vitrectomy for advanced diabetic retinopathy.
    Fulcher T; Acheson RW
    Ir Med J; 1995; 88(1):26-7. PubMed ID: 7737838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results in the use of various cataract extraction methods with simultaneous vitrectomy in patients with proliferative diabetic retinopathy].
    Glinchuk IaI; Iugaĭ AG; Deev LA
    Vestn Oftalmol; 1987; 103(4):38-41. PubMed ID: 3672704
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
    Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
    Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
    Yorston D; Wickham L; Benson S; Bunce C; Sheard R; Charteris D
    Br J Ophthalmol; 2008 Mar; 92(3):365-8. PubMed ID: 18303158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitrectomy for diabetic macular edema associated with hyaloid posterior traction].
    Rasquin F; Demols P; Vanheesbeke A; Schrooyen M
    Bull Soc Belge Ophtalmol; 2000; 276():43-8. PubMed ID: 10925526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Findings of electrophysiological studies at various stages of combined surgical treatment of patients with proliferative diabetic retinopathy].
    Glinchuk IaI; Kuman IG; Mironova EM; Deev LA; Pletnikova NK
    Vestn Oftalmol; 1989; 105(1):36-40. PubMed ID: 2718308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of posterior hyaloid membrane to pathogenesis and transciliary surgery of proliferative diabetic retinopathy].
    Sdobnikova SV; Stoliarenko GE
    Vestn Oftalmol; 1999; 115(1):11-3. PubMed ID: 10232994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in vitreous surgery for proliferative diabetic retinopathy.
    Schönfeld CL; Schneider T; Körner U; Heidenkummer HP; Kampik A
    Ger J Ophthalmol; 1994 May; 3(3):137-43. PubMed ID: 8038681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathy.
    Gurelik G; Coney JM; Zakov ZN
    Ophthalmic Surg Lasers Imaging; 2004; 35(2):94-102. PubMed ID: 15088818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy.
    Hoerle S; Poestgens H; Schmidt J; Kroll P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):197-201. PubMed ID: 11935276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the role of the posterior hyaloid membrane in the pathogenesis of and surgery for proliferative diabetic retinopathy].
    Sdobnikova SV; Stoliarenko GE; Fedorov AA; Marchenko NR
    Vestn Oftalmol; 1996; 112(4):5-7. PubMed ID: 9019911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataract surgery and YAG-laser capsulotomy following vitrectomy for diabetic retinopathy.
    Helbig H; Kellner U; Bornfeld N; Foerster MH
    Ger J Ophthalmol; 1996 Nov; 5(6):408-14. PubMed ID: 9479527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.